Sulforaphane in Treating Patients With Recurrent Prostate Cancer
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well sulforaphane works in treating patients with recurrent
prostate cancer. Sulforaphane may prevent or slow the growth of certain cancers.